Tourette's device tested by Lewis Capaldi reduces tics in trial

United Kingdom News News

Tourette's device tested by Lewis Capaldi reduces tics in trial
United Kingdom Latest News,United Kingdom Headlines
  • 📰 bbcemt
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

A trial of 121 people finds they experienced, on average, a reduction in tic frequency of 25%

By Jennifer Harby & Navtej JohalA wrist device tested by Scottish singer Lewis Capaldi has been shown to reduce tics in those with Tourette's syndrome.

Tourette's syndrome is a neurodevelopmental condition that is usually diagnosed between the ages of eight and 12.Trial participants used the device at home at a similar time each day for 15 minutes for a period of one month.The device is worn on the wrist and delivers electrical pulses In total, 59% of the people who received active stimulation experienced a reduction in tic severity of at least 25%.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

bbcemt /  🏆 120. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Level of 25-hydroxyvitamin D and vitamin D receptor in diabetic foot ulcer and factor associated with diabetic foot ulcers - Diabetology & Metabolic SyndromeLevel of 25-hydroxyvitamin D and vitamin D receptor in diabetic foot ulcer and factor associated with diabetic foot ulcers - Diabetology & Metabolic SyndromeBackground At present, there is no clinical study to elucidate the correlation between vitamin D deficiency and the incidence of diabetic foot osteomyelitis (DFO).This study aims to clarify levels of 25-hydroxyvitamin D [25(OH)VD] in peripheral blood and vitamin D receptor (VDR) expression in wound margin tissues (T-VDR) of patients with type 2 diabetes mellitus (T2DM) with diabetic foot ulcer (DFU) and DFO, and to determine its correlation with treatment outcomes of DFU and DFO, and and its value as a potential biomarker for the diagnosis of DFU and DFO. Methods 156 T2DM patients with DFU (DFU group), 100 T2DM patients without DFU (T2DM group), and 100 healthy controls (NC group). The DFU group patients were subdivided into DFO (n = 80) and NDFO groups (n = 76). The level of serum 25(OH)VD was measured via chemiluminescence immunoassay, and T-VDR expression level was determined by quantitative real-time PCR. Results The levels of serum 25(OH)VD in the DFU group were significantly lower than the T2DM group [(10.3 (5.8, 18.7) vs 15.7 (8.6, 24.6) ng/mL, P = 0.002)]. Similarly, the levels of serum 25(OH)VD and T-VDR expression in the DFO group were statistically lower than the NDFO group [9.2 (5.2, 20.5) vs 12.8 (6.9, 22.1) ng/mL, P = 0.006)], [1.96 (0.61, 3.97) vs 3.11 (1.36, 5.11), P = 0.004)], respectively. Furthermore, the levels of serum 25(OH)VD and T-VDR expression in DFU patients were positively correlated with the ulcer healing rate of foot ulcer after 8 weeks of treatment ( P = 0.031, P = 0.016, respectively). Multivariate logistic regression analysis showed that low level of serum 25(OH)VD was an independent risk factor for DFU and DFO (ORDFU = 2.42, ORDFO = 3.05, P = 0.008, 0.001, respectively), and decreased T-VDR expression level was an independent risk factor for DFO (OR = 2.83, P = 0.004). Meanwhile, the ROC curve analysis indicated that the AUC of serum 25(OH)VD level for the diagnosis of DFU and DFO was 0.821 (95% CI, 0.754–0.886, P | 0.001) and 0.786
Read more »

Topeak Taillux 25 DFTopeak Taillux 25 DFReasonably priced with a wide lighting spread and a handy accessories mount, but not powerful enough for very bright days
Read more »

Clinical and serological association of plasma 25-hydroxyvitamin D (25(OH)D) levels in lupus and the short-term effects of oral vitamin D supplementation - Arthritis Research & TherapyClinical and serological association of plasma 25-hydroxyvitamin D (25(OH)D) levels in lupus and the short-term effects of oral vitamin D supplementation - Arthritis Research & TherapyBackground and objectives Data on the association of vitamin D levels and clinical phenotype and disease activity in systemic lupus erythematosus (SLE) is controversial. Further, the optimal dose of oral vitamin D supplementation in SLE is not clear. Thus, the present study was designed to determine the association of plasma vitamin D levels with clinical phenotype, disease variables and serology in a large, cohort of SLE from South Asia and to evaluate the short-term effect of two different dosage regimens of oral vitamin D supplementation on disease flares and plasma vitamin D levels. Methods This is a two-phase study. Phase I was a cross-sectional analytical study of patients from north (26.85° N) and south India (11.94° N). Plasma 25-hydroxyvitamin-D(25(OH)D) was measured, and its association with demography, serology, disease activity, Galectin-9 and CXCL-10 was analysed. In phase II, patients with SLEDAI-2KG | 10 and on stable immunosuppression were randomised to receive either high dose (weekly 60,000 U*5, followed by 60,000 U monthly) or routine dose (30,000 U monthly) oral vitamin D. Outcomes were assessed at 6 months Results Phase I included 702 patients with a mean age of 29.46 + 10.7 years. The median plasma vitamin D was 22.83 (13.8–31.8) ng/ml. Deficiency (| 20 ng/ml) was seen in 41.5% of patients. Patients from South India had higher vitamin D levels (27.06 ± 20.21 ng/dl) as compared to North India (17.15 ± 16.07 ng/ml) (p | 0.01). Univariate analyses demonstrated weak negative correlation of vitamin D with SLEDAI2K and positive correlation with age. Galactin-9 had modest correlation with SLEDAI2K but not with vitamin D levels. On multiple linear regression, centre of recruitment (β = 4.37) and age (β=0.18) predicted (p | 0.05) plasma vitamin D levels. In the phase II, 91 randomised to 2 groups completed 6 months. Median change in plasma vitamin D levels was more in high dose (9.5 versus 2.6 ng/ml; p= 0.04). There were 14 SLE flares and six minor adve
Read more »

Feldman's top 25 college football head coaches: Nick Saban is still No. 1Feldman's top 25 college football head coaches: Nick Saban is still No. 1How does BruceFeldmanCFB rank the current college football coaches? 4. Jim Harbaugh, Michigan 7. Lincoln Riley, USC 14. Chip Kelly, UCLA 20. Sonny Dykes, TCU More on what Feldman values most and why Nick Saban is still No. 1 ⤵️
Read more »

Mandel's top 25 college football coach rankings: Has Kirby Smart caught Nick Saban?Mandel's top 25 college football coach rankings: Has Kirby Smart caught Nick Saban?By no means was slmandel ready to move Kirby Smart above Nick Saban in his CFB coaches rankings, but he employed the 1a-1b model. Where does Ryan Day rank? 'I don’t love dropping a guy two spots who’s won 88 percent of his games.' Full rankings ⤵️
Read more »

Good Friday Agreement: Titanic, Leo, Kate and the big leap 25 years onGood Friday Agreement: Titanic, Leo, Kate and the big leap 25 years onIt's 25 years since two blockbuster love stories launched and then ran into serious difficulty - that's right we're talking about TitanicMovie and the Good Friday Agreement, which have more in common than you might think, writes BBCGarethG 🎥💞
Read more »



Render Time: 2025-02-22 17:47:11